Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm
1. Kuehn Law investigates potential fiduciary breaches by Immunovant's directors. 2. Shareholders may seek damages and governance reforms. 3. The investigation involves claims of self-dealing activities. 4. Immediate action may be required due to time constraints for shareholders.